{"name":"Ascenta Therapeutics","slug":"ascenta-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxONVNFTFVTYUdKM0V5UVVOYWJoRWxfMkJnTmk0VmJOVjRXZ3FYYk9ZdG45MUppdzJZcHVBcThmamFaM2ZLdEtzZ3V5NWVyQUZmUEJmbnJjUkRwN0gxT0xHN0xBaURTZzNUMVFHX1lXMllvb0cxVGRXWTE2cU4yVUt4cVdmdEs2VXRZY1NCc3l6ZWwzYnM0TTBSS2tOOWlsRmhoWE9QMzRNQ1VnRDZKSWRkQ3hUYS1xdw?oc=5","date":"2025-12-03","type":"pipeline","source":"fiercebiotech.com","summary":"Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic - fiercebiotech.com","headline":"Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPeHNzWjRwcUJ2Z3MweEtodnVhYkluTFZWNVU4cDFZWWJNUzNyRHVHSUVVS0dQR1JrUFR2OU13QjhIMEp5WDdiNTFaNnZ2ZDJtc0NZbk96dkhSUVQ1ZTMxbVlCOVJNbGloakxNdXBpNlZGNWtzMmlNNzdmZ2dUSi1mbFFwMkFpVlhZWVUyYm5mQk9zeTNXcjR4ME02bGNYRDA?oc=5","date":"2025-10-10","type":"pipeline","source":"The Pharma Letter","summary":"Ascenta Capital closes $325 million debut biotech fund - The Pharma Letter","headline":"Ascenta Capital closes $325 million debut biotech fund","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPazBERjhWNXA2YzRIaFEwSGw5NmFMb3BNQmZCSlJ4SkZodUtKYkNYUXNEcWIzeEpCeDNXN3hfSFFEOUlCZHBXekJRcjZuOXZJZThpWUp6VlUyMWVacHNLOFlkaGU2cTZYZ09lejY4SnVOZ3VTclg4ZlRwMDlKM1AzS0l6R2tOVmhZM2Niazk1NDdRbWZO?oc=5","date":"2025-10-10","type":"pipeline","source":"refreshmiami.com","summary":"Ascenta Capital closes $325M inaugural fund to back biotechs - refreshmiami.com","headline":"Ascenta Capital closes $325M inaugural fund to back biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUUFFVk5GMnhLbm1kYl9WNW5yRTFNRzdUejlhdXNHSnVoT0tiTUZKRW50ZUNTbUtQY1Qxejd0VWluZ1AxOUNIRVZxMkZQVjg3UUt3ckpBWm5WV0ljYTUzNFNIRjM3VTRkb25RSTI1Q0h5a2tGQmQxZ2hYbkFaLUpHZVlVSk5WbHFPOWZvWEhEeFVXbXBxdWZ1dWFITFl3c0VnU0pqNnpTV2w4QQ?oc=5","date":"2025-10-09","type":"pipeline","source":"fiercebiotech.com","summary":"2 ex-Moderna leaders unveil $325M inaugural VC fund for platform biotechs - fiercebiotech.com","headline":"2 ex-Moderna leaders unveil $325M inaugural VC fund for platform biotechs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5CeDRuSnlHUGlsYVRZWWxDUzVDaHZhLVkzeHk2dHh6bFZpbklkdlJCS0pyRVhVWHQzSEo4c3RpbEdEMG8xZjNSa1ZuSzBRd3VoSzVJ?oc=5","date":"2025-10-09","type":"pipeline","source":"FirstWord Pharma","summary":"Ascenta to deploy $325M first fund for 'exceptional biotechs' - FirstWord Pharma","headline":"Ascenta to deploy $325M first fund for 'exceptional biotechs'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNUU45QUxIdXNvemM3ZjBiTUk4M0Y3Wld0bWJuMm03dFRocUozV2VVVmh2ZnMyUmlSYjZydDhLMm5PQXlJdDFxWmpvdU0yUWFKUEt4MmZ6Qm1NMHNNWjkzU0JiZ3Q1TGo1QTdyLURIemxlWnRET2Z2TF85SUhJQ2Ywdi1nYjBldTBKQlNYRG1FWEw4ZHozUmk5NGJ0V21PZjh3SWNIZkJYSjZfOENzNHlGSGY2Tjc?oc=5","date":"2024-07-23","type":"pipeline","source":"Inside Precision Medicine","summary":"Cardurion Raises $260M to Advance Novel CV Drugs - Inside Precision Medicine","headline":"Cardurion Raises $260M to Advance Novel CV Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQX3I1ZjFON1hNcHF1enBWR3pPNHd2SlhyOGwzMVF3WEZtNExjTGh6WW12ZzNCLU80cldqejJxV25BRjFsNHJIbXRBcWFVTmYzWnJOcF9MVHZrdHpsaF9zdDdPSWJXZWxxcnFDOS1MblhONldnc0c1cFExWnZOR1k5Tzc4Y3BVUVRsaXhFUE9GWHRWN1J1SHozS0R3VWNEUQ?oc=5","date":"2024-07-16","type":"pipeline","source":"fiercebiotech.com","summary":"Cardio-focused Cardurion closes hearty $260M series B to challenge statin-dominated status quo - fiercebiotech.com","headline":"Cardio-focused Cardurion closes hearty $260M series B to challenge statin-dominated status quo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNWUFMaXhzc2dyX0VRU3ZKRXpHUW12RXdSNjBYcnJ6cXdQQnpqR0hHN3lrSDJTdmk1R1RXRGxsM1VoNXBmeUsxXzJIOG9KMzJ2RGpWZWxQWWN5XzdBV215aTYzbU5aaHNCdHlXWVFnaGo1QmQ3SnhBaHd0YnRzX0pUb25fX1lTWkhyS3U3OXpEb3FWWUtlNm5NWjJQTnVTVGhQUWxzR25xN0NEVnpZTElMM1IzSDBqWXZtdjdBRmlPNFI?oc=5","date":"2023-08-09","type":"pipeline","source":"baincapital.com","summary":"ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing - baincapital.com","headline":"ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Fina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQclpwNS0tQ2RiVlhfcldMZmloZHFRVnRTT3F4SFFzRTdzeG1QVUdzSE1iVnpvcGlWNjlVclJPMk5pNlZnRk9DWVZiLXFYUEFIOVF1T0FWSUR2d0ZLbmlpbHdQeXNxSEo0WWxQVEl3YjhLQlE1NmxLX3ozb2VkSElra3FRSTZsY1pzeE55WHdfRDc1dV81Z195Zll4RTNEN1VlQnB1RGI5aWJ3UHJDTkhYRlVaWTZySGhueWVBRVY0eU9xcVhfTy0xLXBmRzZHdw?oc=5","date":"2023-01-20","type":"pipeline","source":"businesswire.com","summary":"ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic - businesswire.com","headline":"ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1uN2R3LUxyenhPQjZqc0RvTmZEaVNwNmQ3dzB2UHBzVmx1NEs0RjRUcHhXcWxHZk9VcnN0NHF2MWlLRFFZY3BFTXVWa244VUNzZjZXakJubW9CU2stSHFWTVZMcTlhYTZJZ1hqUXplZG9EQQ?oc=5","date":"2014-11-28","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"30 Top VC Firms for Biotechs - Genetic Engineering and Biotechnology News","headline":"30 Top VC Firms for Biotechs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}